Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and nicorandil

2-chloro-n(6)cyclopentyladenosine has been researched along with nicorandil in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(nicorandil)
Trials
(nicorandil)
Recent Studies (post-2010) (nicorandil)
2520431,487207428

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davie, CS; Everitt, DE; Standen, NB1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and nicorandil

ArticleYear
Increase in the vasorelaxant potency of K(ATP) channel opening drugs by adenosine A(1) and A(2) receptors in the pig coronary artery.
    European journal of pharmacology, 1999, Oct-27, Volume: 383, Issue:2

    Topics: Adenosine; Animals; ATP-Binding Cassette Transporters; Coronary Vessels; Cromakalim; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; KATP Channels; Nicorandil; Phenethylamines; Pinacidil; Potassium Channels; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Swine; Triazines; Triazoles; Vasodilator Agents; Xanthines

1999